Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at NOK 191.6B, ahead of Merck & Co (NOK 141.6B) and Novartis (NOK 111.1B). Figures as of 19 Nov 2026, 05:32 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonNOK 191.6B
- Median
- NOK 5.6B
- Combined market value
- NOK 49.17T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | NOK 191.6B | NOK 6.38T | NOK 2,650.54 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | NOK 141.6B | NOK 3.3T | NOK 1,339.17 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | NOK 111.1B | NOK 2.85T | NOK 1,508.58 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | NOK 99.2B | NOK 1.18T | NOK 578.90 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | NOK 82.8B | NOK 1.76T | NOK 1,015.51 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | NOK 82.6B | NOK 1.1T | NOK 457.99 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | NOK 70.6B | NOK 11.97T | NOK 13,439.80 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | NOK 55.5B | NOK 2.69T | NOK 1,737.48 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | NOK 50.8B | NOK 4.91T | NOK 2,779.91 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | NOK 49.4B | NOK 1.32T | NOK 5,214.09 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | NOK 44.2B | NOK 448.1B | NOK 3,922.84 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | NOK 43.8B | NOK 946.5B | NOK 472.18 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | NOK 38.2B | NOK 1.69T | NOK 383.24 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | NOK 36.2B | NOK 660.5B | NOK 206.74 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | NOK 34.6B | NOK 478.9B | NOK 410.46 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | NOK 30.3B | NOK 950.7B | NOK 9,190.19 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | NOK 22.5B | NOK 337.9B | NOK 831.71 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | NOK 16.7B | NOK 305.5B | NOK 495.41 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | NOK 16.1B | NOK 194.5B | NOK 1,452.11 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | NOK 15.1B | NOK 239B | NOK 5,611.53 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | NOK 13.8B | NOK 272.8B | NOK 376.44 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | NOK 13.5B | NOK 154.6B | NOK 2,408.23 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | NOK 12.9B | NOK 226B | NOK 197.11 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | NOK 12.7B | NOK 115.7B | NOK 597.08 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | NOK 11.1B | NOK 1.55T | NOK 272.73 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | NOK 9.6B | NOK 48.9B | NOK 585.41 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | NOK 8.9B | NOK 56B | NOK 82.33 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | NOK 8.8B | NOK 30.6B | NOK 157.94 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | NOK 6.6B | NOK 172.4B | NOK 2,627.50 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | NOK 6B | NOK 383.8B | NOK 667.45 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | NOK 5.6B | NOK 71.3B | NOK 814.80 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | NOK 5.5B | NOK 147.7B | NOK 758.23 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | NOK 5.3B | NOK 129.7B | NOK 259.51 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | NOK 5B | NOK 255.4B | NOK 1,164.41 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | NOK 3.8B | NOK 76.5B | NOK 455.36 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | NOK 3.6B | NOK 44.3B | NOK 266.22 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | NOK 3.5B | NOK 82.9B | NOK 2,966.33 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | NOK 3.4B | NOK 61.7B | NOK 1,518.50 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | NOK 3.1B | NOK 68.5B | NOK 1,302.43 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | NOK 3B | NOK 47B | NOK 270.30 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | NOK 2.9B | NOK 58.7B | NOK 898.97 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | NOK 2.7B | NOK 74.1B | NOK 212.67 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | NOK 2.5B | NOK 38.7B | NOK 283.04 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | NOK 2.2B | NOK 59.2B | NOK 419.01 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | NOK 2.2B | NOK 81.6B | NOK 102.06 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | NOK 1.9B | NOK 89.9B | NOK 3,869.19 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | NOK 1.7B | NOK 58.1B | NOK 2,903.35 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | NOK 1.6B | NOK 72.6B | NOK 923.85 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | NOK 1.6B | NOK 121.4B | NOK 145.60 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | NOK 1.2B | NOK 80.7B | NOK 1,235.95 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | NOK 1.2B | NOK 69.5B | NOK 498.81 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | NOK 1.2B | NOK 72.1B | NOK 658.89 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | NOK 904.3M | NOK 46.9B | NOK 488.31 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | NOK 833.2M | NOK 93.7B | NOK 986.15 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | NOK 769.3M | NOK 97.1B | NOK 642.66 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | NOK 717.4M | NOK 46.9B | NOK 133.74 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | NOK 594.3M | NOK 44B | NOK 402.10 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | NOK 527.8M | NOK 80.2B | NOK 1,157.02 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | NOK 496.5M | NOK 46B | NOK 816.25 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | NOK 456.2M | NOK 63.1B | NOK 930.56 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | NOK 211.6M | NOK 51.2B | NOK 1,213.59 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7196 NOK).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (NOK 191.6B), Merck & Co (NOK 141.6B) and Novartis (NOK 111.1B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 19 Nov 2026, 05:32 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of NOK 49.17T as of 19 Nov 2026, 05:32 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.